Curexo Inc. (060280.KQ)

KRW 6560.0

(-4.51%)

Net Income Summary of Curexo Inc.

Curexo Inc.'s latest annual net income in 2023 was -4.85 Billion KRW , down -59.69% from previous year.
Curexo Inc.'s latest quarterly net income in 2024 Q2 was -1.44 Billion KRW , down -288.68% from previous quarter.
Curexo Inc. reported an annual net income of -3.04 Billion KRW in 2022, down -29.85% from previous year.
Curexo Inc. reported an annual net income of -2.34 Billion KRW in 2021, down -662.1% from previous year.
Curexo Inc. reported a quarterly net income of -1.44 Billion KRW for 2024 Q2, down -288.68% from previous quarter.
Curexo Inc. reported a quarterly net income of 1.86 Billion KRW for 2023 Q1, up 187.03% from previous quarter.

Annual Net Income Chart of Curexo Inc. (2023 - 2016)

Historical Annual Net Income of Curexo Inc. (2023 - 2016)

Year	Net Income	Net Income Growth
2023	-4.85 Billion KRW	-59.69%
2022	-3.04 Billion KRW	-29.85%
2021	-2.34 Billion KRW	-662.1%
2020	416.63 Million KRW	101.61%
2019	-25.91 Billion KRW	11.9%
2018	-29.42 Billion KRW	-74.24%
2017	-16.88 Billion KRW	-169.91%
2016	24.15 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-370.65 Million KRW	95.77%
2024 Q2	-1.44 Billion KRW	-288.68%
2023 Q1	1.86 Billion KRW	187.03%
2023 Q2	1.5 Billion KRW	-19.48%
2023 Q3	535.38 Million KRW	-64.34%
2023 Q4	-8.75 Billion KRW	-1735.79%
2023 FY	-4.85 Billion KRW	-59.69%
2022 Q2	-1.34 Billion KRW	-226.93%
2022 FY	-3.04 Billion KRW	-29.85%
2022 Q4	-2.14 Billion KRW	-359.33%
2022 Q3	826.28 Million KRW	161.63%
2022 Q1	-410.08 Million KRW	30.87%
2021 FY	-2.34 Billion KRW	-662.1%
2021 Q4	-593.17 Million KRW	45.28%
2021 Q3	-1.08 Billion KRW	0.0%
2020 FY	416.63 Million KRW	101.61%
2019 FY	-25.91 Billion KRW	11.9%
2018 FY	-29.42 Billion KRW	-74.24%
2017 FY	-16.88 Billion KRW	-169.91%
2016 FY	24.15 Billion KRW	0.0%

Peer Net Income Comparison of Curexo Inc.

Name	Net Income	Net Income Difference
Osang Healthcare Co.,Ltd	116.43 Billion KRW	104.171%
InBody Co.,Ltd	36.72 Billion KRW	113.223%
Seegene, Inc.	669.01 Million KRW	825.85%
i-SENS, Inc.	3.7 Billion KRW	230.923%
Ray Co., Ltd.	-2.14 Billion KRW	-126.249%
Gencurix Inc.	-19.26 Billion KRW	74.787%
Sugentech Inc.	-17.23 Billion KRW	71.83%
L&C Bio Co., Ltd	48.36 Billion KRW	110.041%